Femarelle (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Femarelle" in Portuguese language version.

refsWebsite
Global rank Portuguese rank
4th place
8th place
2nd place
4th place
610th place
360th place

doi.org

dx.doi.org

  • Somjen D, Katzburg S, Knoll E; et al. (2007). «DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM)». J. Steroid Biochem. Mol. Biol. 104 (3-5): 252–8. PMID 17428655. doi:10.1016/j.jsbmb.2007.03.004 
  • Yoles I, Yogev Y, Frenkel Y, Nahum R, Hirsch M, Kaplan B (2003). «Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss». Menopause. 10 (6): 522–5. PMID 14627860. doi:10.1097/01.GME.0000064864.58809.77 
  • Yoles I, Lilling G (2007). «Pharmacological doses of the natural phyto-SERM DT56a (Femarelle) have no effect on MCF-7 human breast cancer cell-line». Eur. J. Obstet. Gynecol. Reprod. Biol. 130 (1): 140–1. PMID 16580119. doi:10.1016/j.ejogrb.2006.02.010 
  • Oropeza MV, Orozco S, Ponce H, Campos MG (2005). «Tofupill lacks peripheral estrogen-like actions in the rat reproductive tract». Reprod. Toxicol. 20 (2): 261–6. PMID 15878261. doi:10.1016/j.reprotox.2005.02.007 
  • Somjen D, Katzburg S, Lieberherr M, Hendel D, Yoles I (2006). «DT56a stimulates gender-specific human cultured bone cells in vitro». J. Steroid Biochem. Mol. Biol. 98 (1): 90–6. PMID 16243521. doi:10.1016/j.jsbmb.2005.08.002 

elsevier.com

linkinghub.elsevier.com

nih.gov

ncbi.nlm.nih.gov

  • Somjen D, Katzburg S, Knoll E; et al. (2007). «DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM)». J. Steroid Biochem. Mol. Biol. 104 (3-5): 252–8. PMID 17428655. doi:10.1016/j.jsbmb.2007.03.004 
  • Somjen D, Yoles I (2003). «DT56a stimulates creatine kinase specific activity in vascular tissues of rats». J. Endocrinol. Invest. 26 (10): 966–71. PMID 14759068 
  • Somjen D, Yoles I (2003). «DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus». J. Steroid Biochem. Mol. Biol. 86 (1): 93–8. PMID 12943748 
  • Yoles I, Yogev Y, Frenkel Y, Hirsch M, Nahum R, Kaplan B (2004). «Efficacy and safety of standard versus low-dose Femarelle (DT56a) for the treatment of menopausal symptoms». Clin Exp Obstet Gynecol. 31 (2): 123–6. PMID 15266766 
  • Yoles I, Yogev Y, Frenkel Y, Nahum R, Hirsch M, Kaplan B (2003). «Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss». Menopause. 10 (6): 522–5. PMID 14627860. doi:10.1097/01.GME.0000064864.58809.77 
  • Yoles I, Lilling G (2007). «Pharmacological doses of the natural phyto-SERM DT56a (Femarelle) have no effect on MCF-7 human breast cancer cell-line». Eur. J. Obstet. Gynecol. Reprod. Biol. 130 (1): 140–1. PMID 16580119. doi:10.1016/j.ejogrb.2006.02.010 
  • Oropeza MV, Orozco S, Ponce H, Campos MG (2005). «Tofupill lacks peripheral estrogen-like actions in the rat reproductive tract». Reprod. Toxicol. 20 (2): 261–6. PMID 15878261. doi:10.1016/j.reprotox.2005.02.007 
  • Somjen D, Katzburg S, Lieberherr M, Hendel D, Yoles I (2006). «DT56a stimulates gender-specific human cultured bone cells in vitro». J. Steroid Biochem. Mol. Biol. 98 (1): 90–6. PMID 16243521. doi:10.1016/j.jsbmb.2005.08.002